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Central to the pathology of malaria disease are the repeated cycles of parasite invasion and destruction of human
erythrocytes. In Plasmodium falciparum, the most virulent species causing malaria, erythrocyte invasion involves
several specific receptor–ligand interactions that direct the pathway used to invade the host cell, with parasites
varying in their dependency on these different pathways. Gene disruption of a key invasion ligand in the 3D7 parasite
strain, the P. falciparum reticulocyte binding-like homolog 2b (PfRh2b), resulted in the parasite invading via a novel
pathway. Here, we show results that suggest the molecular basis for this novel pathway is not due to a molecular
switch but is instead mediated by the redeployment of machinery already present in the parent parasite but masked
by the dominant role of PfRh2b. This would suggest that interactions directing invasion are organized hierarchically,
where silencing of dominant invasion ligands reveal underlying alternative pathways. This provides wild parasites with
the ability to adapt to immune-mediated selection or polymorphism in erythrocyte receptors and has implications for
the use of invasion-related molecules in candidate vaccines.
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Introduction
Unlike many other members of the phylum Apicomplexa,
malaria parasites limit their infection of host cells to the
restricted population of erythrocytes in the bloodstream. The
invasion of erythrocytes and the subsequent cycles of growth,
replication, and rupturing of infected cells are responsible
for the majority of symptoms relating to malaria disease, with
severe parasite infections giving rise to rapid hemolysis and
metabolic acidosis [1]. This makes the blood stage of the
parasite life cycle a primary target for novel interventions to
prevent invasion and combat malaria disease.
Erythrocyte invasion is a rapid process governed by
molecular interactions between the invading blood-stage
parasite, the merozoite, and the host cell surface [2]. The
merozoites bind to the erythrocyte surface, reorientate to
their apical pole, and then, following formation of a tight
junction between host and parasite apical tip (Figure 1A),
invade, forming an isolated parasitophorous vacuole [2]. In
Plasmodium falciparum, the most virulent of malaria species
infecting humans, studies with erythrocytes modiﬁed by
enzyme treatment [3–11], or from human donors lacking
surface antigens [5,6,12–16], have identiﬁed a number of
erythrocyte receptors used by merozoites for attachment
(Figure 1B). These include glycophorins A [17], B [12], and C
[14] as well as unknown receptors referred to as X [12], Y [7], Z
[8], and E [10]. The dependency on these receptors for
invasion is known to vary among parasites both in laboratory
strains [12,15,18,19] and in isolates from the ﬁeld [20–22].
Furthermore, in certain laboratory strains, such as W2mef
(and its clone Dd2), the dependency on different receptors
for invasion can change following either disruption of the
host receptor [9] or targeted modiﬁcation of the parasite
ligand to which it binds [8,23].
The specialized apical complex that deﬁnes all Apicom-
plexan parasites contains two main vesicular bodies, termed
micronemes and rhoptries (Figure 1A). Two families of
parasite proteins that localize to these organelles are thought
to underlie the receptor dependency of different parasite
strains. The ﬁrst family shares homology with the Duffy
binding protein from Plasmodium vivax [24] and includes
erythrocyte-binding antigen 175 (EBA-175) [17], EBA-140
[11,14] (also known as BAEBL [24]), and EBA-181 [10] (also
known as JESEBL [24]). The EBA proteins bind sialic acid (SA)
residues of glycophorins A, C, and the unknown receptor E,
respectively, on the erythrocyte surface and are therefore
sensitive to treatment by the sialidase neuraminidase (Figure
1B) [4,10,14,25]. The second group of proteins is a high-
molecular-weight, family-sharing homology with the retic-
ulocyte-binding proteins of P. vivax [26]. These include the P.
falciparum reticulocyte binding-like homolog 1 (PfRh1) [7,27],
PfRh2a, and PfRh2b [8,28], and PfRh4 proteins [29] (also
known as NBP proteins 1, 2a, 2b, and 4 [7,28,29]). PfRh1
binding to the erythrocyte surface via an unknown receptor Y
is SA-dependent, whereas the inferred binding characteristic
of PfRh2b (to its unknown receptor Z) and PfRh4 are SA-
independent (Figure 1B). Binding characteristics of PfRh2a
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expression of the functional EBA and PfRh proteins in
different parasite lines, a factor that may underlie the use of
alternative invasion pathways [8,27]. Both families also
include proposed pseudogenes EBA-165 (PFD1155w) [30]
and PfRh3 (PFL2520w) [31], respectively, which are tran-
scribed but do not appear to form protein products.
The 3D7 strain of P. falciparum has been fully sequenced
[32], and can invade erythrocytes in both a SA-dependent and
independent manner [8]. Previous studies have successfully
disrupted the expression of EBA-140 [14], EBA-175 [33],
PfRh1, PfRh2a, and PfRh2b [8] in 3D7 by gene knockout
strategies. In each case this did not result in any measurable
change in efﬁciency of invasion into normal erythrocytes,
demonstrating that there is considerable redundancy in
invasion pathways and that the role of each protein is either
expendable or can be readily compensated [8,14,33]. The
3D7DEBA-175 parasites invade chymotrypsin-treated eryth-
rocytes at a greatly reduced rate when compared to the
parental 3D7 strain. This suggests that EBA-175 is functional
in the parent, and as a result of the gene disruption, the
mutant parasite has a reduced repertoire of potential
invasion receptors [14,33], although on which alternative
receptor(s) it is relying is not known. Disruption of PfRh1,
PfRh2a, or EBA-140 in 3D7 does not result in any noticeable
alteration in the sensitivity of invasion, even in enzyme-
treated erythrocytes, suggesting these proteins play a less
important role in the parent [8,14,27]. Unlike the other
knockout lines and 3D7 parent, the 3D7DRh2b parasite uses
receptors that are chymotrypsin-resistant [8]. This suggests
that an invasion pathway, not normally used by the parent
strain, has been utilized in the mutant parasite. This mirrors
the phenotype observed when EBA-175 function is removed
in W2mef (a parasite usually sensitive to neuraminidase),
resulting in a dramatic shift to SA-independent invasion [23].
Here we have analyzed the novel invasion pathway used by
the 3D7DRh2b parasite. Our results suggest that changes in
the receptor–ligand dependency of parasites are directed by a
hierarchy of molecular interactions and not, at least in the
case of 3D7, by the activation of new ligands. This mechanism
would provide parasites with the ability to rapidly adapt to
host immune selection directed at primary invasion ligands
or to polymorphism in erythrocyte receptors.
Results
PfRh3 Is Activated in 3D7DRh2b Parasites
A number of genes that encode invasion-related proteins
have been disrupted in the P. falciparum parasite strain 3D7
[8,14,33]. However, so far only the 3D7DRh2b parasite,
lacking the PfRh2b gene, alters its invasion receptor depend-
ency, utilizing erythrocyte receptors that are more resistant
to chymotrypsin than the parent [8,11]. To investigate the
molecular basis for this novel invasion pathway, transcription
of key invasion-related genes in late-stage (40–48 h post-
Figure 1. A Number of Receptor–Ligand Interactions Mediate Merozoite Invasion of the Erythrocyte
(A) Estimates for the dimensions of the interaction between the apical merozoite tip and the erythrocyte surface suggest a finite number of receptors
may, together with parasite ligands, direct invasion (dimensions based on [55]; receptor figures based on [56]).
(B) Known receptor–ligand interactions between the invading merozoite and erythrocyte surface receptors and their enzyme sensitivities to
neuraminidase (Nm), trypsin, and chymotrypsin (Chymo). S indicates sensitivity of invasion to this enzyme (inhibits invasion/ligand-binding). R indicates
resistance (does not inhibit invasion/ligand-binding). Unknown ligands or receptors are indicated by a ‘‘?,’’ with unknown receptors E, X, Y, and Z
known only from their enzyme sensitivities. Dots in table indicate that no data are available. Data are taken from [7,8,10–12,14,17,27,33,45].
DOI: 10.1371/journal.ppat.0010037.g001
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Synopsis
The repeated cycles of parasite invasion and destruction of human
red cells is central to malaria disease. In Plasmodium falciparum, the
most virulent species that causes malaria, invasion involves the
interaction of several parasite ligands with receptors that line the
red cell surface. Central to the success of the P. falciparum parasite is
its ability not only to utilize a number of these receptors but also to
vary the primary route used. Here we show that in some parasite
strains when you remove their key invasion ligands, rather than
activating an alternative molecular machinery to compensate, the
parasite has at its disposal a secondary means of invading that was
present in the parent parasite but whose role was masked by the
dominant invasion route. This suggests that the interactions that
direct invasion are organized hierarchically, where silencing of the
dominant ligand reveals underlying alternative means to invade.
Such a mechanism gives the parasite population the ability to avoid
host immune-mediated selection or to adapt to variation in red cell
surface receptors and still successfully infect the human host. This
stresses the importance of directing a blood-stage malaria vaccine at
multiple receptor–ligand interactions to prevent parasite adaptation
to invade via alternative routes.invasion) 3D7 and 3D7DRh2b parasites was measured. The
unrelated isolate D10 was included as it naturally lacks the
PfRh2b gene, as well as the EBA-140 gene, and invades in a
chymotrypsin-resistant manner similar to 3D7DRh2b [8]. The
relative amount of RNA transcribed (relative to either the
actin and histone 2b genes, or the late-stage expressed msp2
gene) for the EBA (EBA-140, EBA-165, EBA-175, and EBA-181)
and PfRh (PfRh1, PfRh2a, PfRh2b, PfRh3, and PfRh4) families of
genes is shown in Figure 2. As predicted, transcription of the
PfRh2b in both 3D7DRh2b and D10 was greatly reduced (or
absent) when compared to wild-type 3D7 (Figure 2A and 2B).
The absence of EBA-140 was also conﬁrmed for D10 (Figure
2B). Among the PfRh and EBA genes, the only gene that
showed signiﬁcant increases in relative levels of RNA tran-
script, in comparison to 3D7, was PfRh3, ap u t a t i v e
pseudogene. This gene appeared to be transcribed approx-
imately 10-fold more in both 3D7DRh2b and D10 relative to
3D7 (Figure 2A and 2B).
To conﬁrm the apparent activation of PfRh3 in 3D7DRh2b
and D10 and investigate other genes that may have changed
with the loss of the PfRh2b gene, we probed Affymetrix gene-
chips representing 95% of the predicted genes in the 3D7 P.
falciparum genome [34]. Global analysis of expression carried
outusingtheMOID[35],RMA[36],andGCRMAalgorithms[37]
showed a number of genes that have changed their tran-
scription levels between parasite lines (Dataset S1). Measure-
ments from replicate chips were used to calculate a moderated
t-statistic. The t-statistic is used to rank genes in order of
conﬁdence of differential expression [38]. Analysis was re-
stricted to those genes that are expressed at similar times to
genes whose products are known to be involved in invasion
(clusters 4, 13, 14, and 15 [34]) but excluding the known
virulencegenes(vars,riﬁns,andstevors[39]),leavingatotalof548
genes(DatasetsS1–S4).Asexpected,PfRh2bisdownregulatedin
both 3D7DRh2b and D10, as is EBA-140 in D10. To investigate
whichgenemighthavebeenupregulatedtocompensateforloss
of PfRh2b, a low cutoff point of t greater than or equal to 2 was
chosen to deﬁne those genes that have increased their
transcription between the 3D7DRh2b or D10 parasite and
3D7 wild type. By this cutoff, and comparison between the
algorithms, seven genes showed signiﬁcant increase in tran-
scriptionalactivityinthe3D7DRh2b(Figure2C;Table1).PfRh3
Figure 2. Comparison of Transcription of Key Invasion Genes in 3D7, 3D7DRh2b, and D10
(A and B). Expression levels of EBA and PfRh genes controlled by the relative expression of either actin and histone 2b (two constitutively expressed
genes) or msp2 (a gene expressed later on in the life cycle). Error bars represent the 95% confidence interval (CI) of values from two to three
independent amplifications.
(C and D) Affymetrix microarray comparison of log gene expression intensity (as measured by MOID) between cRNA isolated from late-schizont 3D7 and
(C) 3D7DRh2b or (D) D10 parasites. Data shown are restricted to 548 genes whose expression profile matches clusters 4, 13, 14, 15 [34], including genes
that encode proteins known to be involved in invasion. Color represents significance of the change in the level of gene expression as measured by the
t-statistic (,2 black, .2 red). The control genes PfRh2b (knocked out) and EBA-140 (deleted in D10) and upregulation of PfRh3 are shown.
DOI: 10.1371/journal.ppat.0010037.g002
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approximately 60-fold and approximately 15-fold, respectively
(values from the MOID calculation, Figure 2D; Table 1),
supporting the result observed using RT-PCR. Of the other
genesthat haveincreasedintranscriptionalactivity(PlasmoDB
ID: PFE1465w, PFB0680w, PFF0670w, PF08_0036,
PF13_0173, and PF14_0567), all are uncharacterized genes
with no obvious adhesive domain and lack a signal peptide and
transmembrane domain. PF08_0036 encodes a putative
protein transporter, which is unlikely to function directly in
invasion. Additionally, and in contrast to PfRh3, even by the
most generous estimates these genes have only increased by 4-
fold in 3D7DRh2b and do not show up regulation in D10.
Therefore,althoughtheirproteinproductsmayplayanindirect
roleinthenewinvasionpathwayof3D7DRh2b,itisunlikelythat
they directly compensate for the loss of function of PfRh2b.
Since PfRh3 transcription was very low in 3D7, its elevated
level in 3D7DRh2b and D10, both of which invade more
efﬁciently into chymotrypsin-treated erythrocytes, may in-
dicate a role for Rh3 in compensating for the loss of function
of Rh2b, and as such deﬁne the molecular basis for the novel
chymotrypsin-insensitive pathway. However, PfRh3 may also
be activated in 3D7DEBA-175 and 3D7DEBA-40, although
these parasites show no change in the phenotype or efﬁciency
of invasion. (Table 1, Datasets S1–S5).
PfRh3 Is Not Essential for the Novel Invasion Pathway
Used by 3D7DRh2b
The presence of a conserved frame-shift mutation(s) in the
PfRh3 gene from multiple parasite lines [40], and the inability
to detect a protein product for the gene using rabbit serum
raised against recombinant portions of the gene [31] suggest
that PfRh3 is a transcribed pseudogene. To investigate
whether the increase in levels of PfRh3 transcript in
3D7DRh2b and D10 was associated with the production of a
functional PfRh3 protein, genomic DNA and cDNA from the
three strains were used as template to amplify a 59 region of
PfRh3. Sequences of this region, from genomic or cDNA, all
retained the 59 frame-shift mutation (data not shown),
suggesting no protein product could be produced. The
possibility that posttranscriptional modiﬁcation might re-
move the frame-shift mutation from PfRh3 mRNA, and
therefore produce a functional protein product, was excluded
by failure of rabbit anti-Rh3 antisera to detect any protein
product from either 3D7DRh2b or D10 (data not shown).
To ﬁnally rule out the role of PfRh3 in the 3D7DRh2b
parasite, weconstructeda plasmid(pCC4-Rh3)(Figure3A)that
would integrate into the PfRh3 locus in the 3D7DRh2b parasite
by double recombination crossover [41]. Because the original
3D7DRh2b knockout had been achieved using a vector
containing the human dihydrofolate reductase (hdhfr) gene [8],
the blasticidin-S deaminase gene (BSD, conferring resistance to
blasticidin) was used in pCC4-Rh3 to select for parasites
carrying the plasmid. As a control, knockout of PfRh3 was also
performed in parental 3D7 since, in the absence of other
modiﬁcations, this gene has been easily disrupted previously
[31,41].ToconﬁrmintegrationofpCC4-Rh3intoboth3D7and
3D7DRh2b, genomic DNA from parental and transfected
parasiteswasanalyzedbySouthernhybridization.Thisrevealed
DNA fragments consistent with double-crossover recombina-
tion into the PfRh3 locus (Figure 3B). This represents the ﬁrst
timetwogeneshavebeensequentiallydisruptedinP.falciparum.
To ensure that PfRh3 transcript had been lost from 3D7DRh3
and 3D7DRh2bDRh3 we used RT-PCR with late-stage RNA
fromtheseparasitelinesaswellas3D7and3D7DRh2b.Primers
targeted to a speciﬁc region of PfRh2a showed consistent
expression inall parasites lines(Figure 3C), whilethose speciﬁc
for the region of PfRh3 deleted by the gene-disruption strategy
showed no expression in the PfRh3 knockout lines, conﬁrming
that the gene has been disrupted (Figure 3C).
Finally, to conﬁrm that PfRh3 plays no role in the novel
invasion pathway used by the 3D7DRh2b parasite, 3D7,
3D7DRh2b, 3D7DRh3, and 3D7DRh2bDRh3 were grown in
erythrocytes treated with neuraminidase and chymotrypsin.
Invasion rates into untreated cells were similar for all parasite
lines (data not shown). Invasion into neuraminidase-treated
cells showed similar rates for the 3D7 and 3D7DRh3 parasites
of approximately 75% to that into untreated cells and
approximately 60% in the 3D7DRh2b and 3D7DRh2bDRh3
parasites (Figure 3D). Chymotrypsin treatment similarly
grouped the parasites into those in which PfRh2b had been
disrupted with 3D7 and 3D7DRh3 parasites, invading at
Table 1. Genes That Have Altered Their Transcription Levels .2-Fold in 3D7DRh2b Relative to 3D7 Wild Type with a t-Statistic  2
Parasite Strain PlasmoDB ID 3D7DRh2b D10 3D7D140 3D7D175 Description Features/Homologs
Fold
b t Fold t Fold t Fold t
Genes t
a . 2, and fold .2 PFL2520w 58.6
c 2.5 16.1 1.7 18.1 1.4 12.3 1.2 PfRh3 Reticulocyte-binding protein homolog
PFE1465w 4.0 2.9 2.5 1.9 1.4 0.6 1.9 1.1 Hypothetical TM
d, P. yoelii unknown (PY02786)
PFB0680w 2.8 2.7 1.9 1.7 1.1 0.1  1.3  0.5 Hypothetical TM?, P. yoelii unknown (PY05738)
PFF0670w 2.4 3.1 2.1 2.8 1.2 0.6 1.1 0.3 Hypothetical No obvious domains or homologs
PF08_0036 2.3 2.7  1.0  0.1 1.2 0.6 1.0 0.0 Hypothetical TM, Homo sapiens protein—transport protein Sec23A
PF13_0173 2.0 2.5 1.1 0.4  1.8  1.7  2.3  2.4 Hypothetical No obvious domains or homologs
PF14_0567 1.4 2.3 1.1 0.9 1.1 0.7 1.1 0.3 Hypothetical TM, P. yoelii (PY06532)
Control genes MAL13P1.176  7.6  1.5  94.2  3.4  1.8  0.4  3.7  0.8 PfRh2b
MAL13P1.60 1.4 0.4  38.8  4.9  8.7  2.4  2.1  0.8 EBA-140
PF07_0128 1.4 0.3  1.6  0.5 1.1 0.1  16.3  2.4 EBA-175
at-statistic.
bFold change relative to 3D7 parasite strain.
cGenes are ordered according to relative fold change in the 3D7DRh2b parasite line.
dTransmembrane domain.
DOI: 10.1371/journal.ppat.0010037.t001
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Molecular Hierarchy in Malaria Invasionapproximately 35% to that into untreated cells and between
70%–100% in the 3D7DRh2b and 3D7DRh2bDRh3 parasites.
These ﬁgures are similar to those seen in the original analyses
of 3D7DRh2b [41] and demonstrate that PfRh3 plays no role
in the novel chymotrypsin-resistant pathway.
Therefore, despite the consistent ﬁnding of PfRh3 up-
regulation in both the 3D7DRh2b and D10 parasites, these
data clearly demonstrate that it plays no role in determining
the novel invasion pathway used by 3D7DRh2b. Indeed, PfRh3
activation in both 3D7DEBA-140 and 3D7DEBA-175 (which
do not appear to use this novel pathway) further argues
against a role for PfRh3 in compensating for the loss of
PfRh2b function (Dataset S5). The lack of obvious candidate
genes that have properties consistent with their role in
invasion suggests that proteins that are already present in
3D7 mediate the previously unused pathway.
Relative Levels of Key Invasion Proteins Have Not
Changed between Wild-Type 3D7 and the 3D7DRh2b
Parasite
A number of parasite proteins have been implicated in
mediating the alternative invasion pathways used by P.
Figure 3. Targeted Disruption of PfRh3 Shows It Is Not Essential for the 3D7DRh2b Chymotrypsin-Resistant Pathway
(A) Disruption of the PfRh3 gene in 3D7. The pCC4-Rh3 plasmid contains the blasticidin-S deaminase selectable marker, a negative selectable marker (A.
G. Maier and A. F. Cowman, unpublished data), and 59 and 39 Rh3 regions. PfRh3 is shown with homologous target sequences (shaded regions). The
double-crossover integration events are shown for 3D7, resulting in the deletion of a 59 region of the gene. Restriction enzymes are C (ClaI) and X (XbaI),
with fragment sizes shown for a C/X digestion. RT-PCR amplification target is shown as a black bar.
(B) Southern blot of genomic DNA from parasites shown digested with ClaI and XbaI and probed with the 59 Rh3 flank from the pCC4-Rh3 vector.
(C) RT-PCR of PfRh2a and PfRh3 from 3D7 and three knockout lines.
(D) Invasion into enzyme-treated erythrocytes expressed as a percentage of that into untreated erythrocytes for 3D7 and three knockout lines. Values
above each column indicate the mean % invasion, with error bars representing the 95% CI from three independent assays.
DOI: 10.1371/journal.ppat.0010037.g003
PLoS Pathogens | www.plospathogens.org December 2005 | Volume 1 | Issue 4 | e37 0303
Molecular Hierarchy in Malaria Invasionfalciparum to invade erythrocytes [4,7,8,10,11,14,17]. Although
transcript levels of these invasion-related genes do not
appear to have changed with loss of the PfRh2b gene in
3D7, posttranscriptional modiﬁcation resulting in changes in
the absolute amounts of protein product may underlie the
novel invasion pathway used in the 3D7DRh2b parasite line.
Semiquantitative Western blots, where loading was controlled
for expression of the SERA5 protein, were undertaken to
determine if changes in absolute levels of invasion-related
proteins had occurred (Figure 4A). Other than the absence of
detectable protein in knockout lines (as expected), no
discernable differences are present between the different
3D7 parasite lines for the PfRh1, PfRh2a, PfRh2b, EBA-140,
EBA-175, or EBA-181 proteins (Figure 4A), suggesting that
the absolute levels of the invasion proteins have not changed.
Proteomic analysis of late schizonts from both 3D7 and
3D7DRh2b also failed to show any dramatic changes in the
presence of any particular proteins (unpublished data).
However, as with previous studies [42], invasion genes were
poorly represented in the analysis, with only a few peptide
fragments from one or two proteins showing up. This suggests
that the absolute amount of most invasion proteins is not
sufﬁcient for detection, using current proteomic methods.
This demonstrates that the absolute levels of key invasion
proteins in 3D7, following the disruption of PfRh2b, appear
to remain constant despite a shift in the invasion receptor
dependency.
Invasion Inhibitory Antibodies against EBA-140 and EBA-
175 Inhibit 3D7DRh2b and the Parental 3D7 Strain
The inhibition caused by antibodies raised against re-
combinant EBA-140 and EBA-175 relate directly to the
function of these proteins in invasion, as shown by the
failure of speciﬁc antibodies to inhibit parasites where the
respective genes have been disrupted [14,33]. The binding of
EBA-140 and EBA-175 to the erythrocyte surface is insensi-
tive to chymotrypsin treatment [11] since their receptors,
glycophorins A and C, are resistant to digestion by this
enzyme (although some glycophorin A is sensitive to
chymotrypsin, as much as 60% remains following enzyme
treatment because of a variable glycosylation site near the
enzyme cleavage point [43]). Given that the pathway being
used by 3D7DRh2b is relatively chymotrypsin-resistant
(Figure 4B), alterations in the importance or reliance of
3D7DRh2b on EBA-140 or EBA-175 might underlie this
unidentiﬁed pathway. To address this, invasion assays in the
presence of aEBA-140 and aEBA-175 were undertaken with
the 3D7 mutant parasite lines, 3D7 and D10.
As found previously [14], invasion of 3D7 into untreated
erythrocytes in the presence of aEBA-140 was approximately
80% compared to that in the presence of normal (preimmu-
nization) rabbit serum (NRS) (Table 2; Figure 4C), demon-
strating a role for the EBA-140 protein despite there being no
altered or observable phenotype following the disruption of
its gene in 3D7 [14]. Invasion of 3D7DRh2b in the presence of
aEBA-140 was approximately 70%, the range of which is not
signiﬁcantly different from that in 3D7 (Table 2; Figure 4C).
Both 3D7DEBA-140 and D10 were unaffected by aEBA-140,
conﬁrming the speciﬁcity of the antibody [14]. Interestingly,
in the presence of aEBA-140, 3D7DEBA-175 invasion was
signiﬁcantly less inhibited (approximately 90% invasion) than
wild-type 3D7 or 3D7DRh2b (Table 2; Figure 4C). This
suggests that in the absence of EBA-175, invasion by the
3D7 parasite is entirely SA-independent and no longer relies
on any residual function of EBA-140.
The 3D7, 3D7DRh2b, and 3D7DEBA-140 parasites invaded
erythrocytes at approximately 40% in the presence of aEBA-
175. This adds strong support to the observation that 3D7
Figure 4. Changes in Protein Levels Do Not Underlie the 3D7DRh2b Chymotrypsin-Resistant Pathway
(A) Western blot of parasite culture supernatant material probed with rabbit polyclonal antibodies against the functional EBA and PfRh proteins. SERA5
is used as a loading control. Antibodies marked with an asterisk (*) indicate the same gel stripped and reprobed with a different antibody.
(B) Invasion into chymotrypsin-treated erythrocytes for five parasite lines represented as the percentage of invasion to that into untreated erythrocytes.
(C) Invasion into either untreated or chymotrypsin-treated erythrocytes in the presence of protein-G purified polyclonal rabbit antiserum raised against
recombinant EBA-140 and EBA-175 (or both together). Values are represented as the percentage of invasion in the presence of NRS. Error bars represent
the 95% CI from three independent assays.
DOI: 10.1371/journal.ppat.0010037.g004
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tion to mediate invasion despite being able to invade via
alternative (SA-independent) routes when this pathway is
blocked (for example following neuraminidase treatment)
[33]. Inhibition of 3D7DEBA-140 by EBA-175 antibodies
demonstrates a more dominant role for EBA-175 over EBA-
140. Invasion of 3D7DEBA-175 was not inhibited by aEBA-
175, conﬁrming the speciﬁcity of the antibody [23].
Invasion of 3D7 into erythrocytes pretreated with chymo-
trypsin for all parasite lines conﬁrmed results found
previously (Figure 4B). This enzyme digests many surface
receptors but does not entirely remove glycophorins C or A,
the receptors of EBA-140 and EBA-175, respectively [11]. As
such, by removing a number of other putative receptors, but
leaving glycophorins C and A, chymotrypsin treatment will
accentuate the inhibitory effects of aEBA-140 and aEBA-175.
The relative inhibition of 3D7 with aEBA-140 (compared to
that in the presence of NRS) was reduced to approximately
40% invasion (Table 2; Figure 4C), conﬁrming that reported
previously [14]. However, unlike 3D7, chymotrypsin treat-
ment did not signiﬁcantly reduce the relative inhibition of
3D7DRh2b with aEBA-140, suggesting that EBA-140 plays a
less important role in the PfRh2b knockout parasites.
Following chymotrypsin treatment, 3D7DEBA-140 and D10
showed no inhibition from aEBA-140. This was also true for
3D7DEBA-175, which further supports its shift to reliance on
SA-independent invasion. The lack of reduction in relative
invasion of 3D7DRh2b with aEBA-175 and chymotrypsin
treatment, like that with aEBA-140, demonstrates that the
PfRh2b knockout appears to be less reliant on EBA-175 than
the parent strain; 3D7, the EBA-140 knockout line, and D10,
in the presence of aEBA-175, all showed only a moderate to
no increase in the relative inhibition compared to NRS.
Finally, it is worth noting that inhibition in the presence of
both antibodies together (both with and without chymotryp-
sin treatment) is not dramatically different from that seen in
the presence of aEBA-175 alone (Table 2; Figure 4C). A
caveat to the observations following chymotrypsin treatment
is that our ability to detect subtle differences in invasion is
limited with chymotrypsin treatment since, in both parasites,
it reduces the efﬁciency of invasion and, as such, means that
the absolute numbers of parasites are less in each assay.
Decreased inhibition of invasion in the presence of aEBA-
140 and aEBA-175 demonstrates that without PfRh2b, the
3D7 parasite utilizes receptors other than glycophorins C and
A. Furthermore, it supports the general assertion that in wild-
type 3D7, EBA-175 plays a more critical role than EBA-140 in
mediating invasion.
Long-Term Culturing of 3D7 in Chymotrypsin and Low-
Trypsin-Treated Cells Does Not Lead to a Switch in
Invasion Phenotype
Following selection on enzyme-treated cells, certain para-
site lines (notably W2mef/Dd2) are able to switch their route
of invasion to a previously unused pathway [9]. Having
demonstrated that neither a change in transcription nor a
change in protein levels, or the function (as determined by
inhibition) of alternative invasion ligands, underlies the novel
invasion pathway used by the 3D7DRh2b parasite line, long-
term selection of 3D7 was undertaken to attempt to select for
the chymotrypsin-resistant pathway (thereby mimicking
knockout of the PfRh2b gene), as has been observed with
selection on neuraminidase-treated cells and the knockout of
EBA-175 in W2mef [23]. After selection on chymotrypsin- and
trypsin-treated cells (the most marked phenotype of the new
pathway in 3D7DRh2b) for more than 30 d, no signiﬁcant
change in enzyme sensitivity occurred in 3D7 to make it more
like the 3D7DRh2b parasite (Figure 5A and 5B).
Therefore, even though the underlying mechanism for
invasion into chymotrypsin- and trypsin-treated erythrocytes
appears to be already present in the 3D7 parasite, it cannot
be upregulated when PfRh2b is present. This suggests, that
PfRh2b is the a priori ligand used by 3D7 and that the
physical presence of functional PfRh2b relegates any poten-
tial role of a secondary invasion ligand(s) (and its resulting
chymotrypsin-resistant pathway), reducing the invasion efﬁ-
ciency of 3D7 into certain enzyme-treated cells.
Discussion
The availability of the completed P. falciparum genome has
led to the identiﬁcation of two families of proteins that are
thought to underlie the variable receptor–ligand interactions
used by malaria parasites to invade human erythrocytes. Gene
disruption of each of these EBA and PfRh proteins have been
generated in various parasite lines, and in 3D7, the genome
reference malaria parasite, null mutants for EBA-140, EBA-
165, EBA-175, PfRh1, PfRh2a, PfRh2b, and PfRh3 are available
Table 2. Percentage Invasion of Parasites into Untreated and Chymotrypsin-Treated Erythrocytes in the Presence of IgG-Purified
Rabbit Antiserum Raised against Recombinant EBA-140 and EBA-175
Parasite Strain Antibody 3D7 3D7DRh2b 3D7DEBA-140 3D7DEBA-175 D10
av
a 1.96 3 SEM
b av 1.96 3 SEM av 1.96 3 SEM av 1.96 3 SEM av 1.963 SEM
Untreated aEBA-140 77.7 68.0 67.0 63.3 93.4 62.5 94.0 63.5 97.0 63.8
aEBA-175 44.4 67.0 41.1 65.8 35.9 61.6 97.9 64.2 55.4 69.9
Combined 35.0 67.9 30.4 61.7 —
c —— —— —
Chymotrypsin-treated aEBA-140 42.3 66.5 70.6 68.6 90.8 64.1 88.8 67.3 94.4 66.1
aEBA-175 37.0 68.9 55.9 67.7 14.8 65.1 100.0 60.1 61.7 67.8
Combined 45.0 60.7 44.8 61.2 — — — — — —
aValues represent average % of that in the presence of NRS, using untreated or chymotrypsin-treated erythrocytes, respectively.
b1.96 multiplied by the standard error of the mean (SEM) to give 95% CI.
cNo data.
DOI: 10.1371/journal.ppat.0010037.t002.
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apparently uses an invasion pathway that is qualitatively
different to that of the parent 3D7 strain [8]. Here we have
used speciﬁc gene disruptions and a comparative analysis of
gene and protein expression and function to demonstrate
that the receptor-mediated invasion pathway of 3D7DRh2b
likely uses ligands that are already present in wild-type 3D7,
but our ability to measure their function was masked by the
presence of PfRh2b.
Compensation for the Function of PfRh2b in 3D7
Comparison of gene expression between 3D7 and
3D7DRh2b showed that PfRh3, a related PfRh pseudogene,
does increase its mRNA expression levels signiﬁcantly
following PfRh2b disruption. However, no protein product
is produced (it being a pseudogene [31]). Furthermore, the
possibility that PfRh3 might function at the RNA level is ruled
out by gene disruption on a 3D7DRh2b genetic background.
This is the ﬁrst time two genes have been disrupted
sequentially in the malaria parasite. Previous work analyzing
PfRh transcription in the parasite strains FCB1, T996, and
3D7 showed that PfRh3 levels are naturally much lower in 3D7
than the other two strains [44]. Therefore the explanation for
PfRh3’s anomalous increase in transcription in 3D7DRh2b
might lie with its low levels of transcription in the 3D7 parent
strain, which changes in the knockout parasite. This is
supported by a similar activation of PfRh3, albeit to a smaller
extent, in the 3D7DEBA-140 and 3D7DEBA-175 parasites. The
rigors of transfection and drug selection may induce changes
in gene regulation across the parasite genome that non-
speciﬁcally activates the expression of PfRh3. This anomalous
upregulation would suggest a degree of caution in the
interpretation of comparative microarray data and stress
the importance of following up the functionality of up- or
downregulated gene products following any selection regi-
men.
In addition to PfRh3, a small number of other genes do
change their transcriptional activity (although not to the
same extent as PfRh3). However, lack of obvious domains that
might have an adhesive or binding function, and the absence
of a signal peptide (necessary for export to secretory
organelles or the merozoite surface) or transmembrane
domain would suggest that none of these genes are likely to
play a direct role in invasion. This apparent absence of
change also appears to be true at the protein level for the
k n o w ni n v a s i o np r o t e i n s .T a k e nt o g e t h e r ,t h i ss t r o n g l y
suggests that in 3D7DRh2b, the chymotrypsin-resistant
invasion pathway revealed in the absence of PfRh2b is the
result of a redeployment of the existing ligand repertoire of
the parent parasite and not any transcriptional or posttran-
scriptional change in other invasion ligands.
The Role of Other EBA or Rh Proteins in the Rh2b-
Independent Pathway
A plausible explanation for the 3D7DRh2b parasites’
increased ability to invade chymotrypsin-pretreated eryth-
rocytes is that the parasite has become more reliant on EBA-
175 or EBA-140, both of which bind red cells in a
chymotrypsin-insensitive manner (mediating invasion via
glycophorins A or C) [11,14,23]). However, the reverse seems
to be true since 3D7DRh2b parasites are less inhibited than
wild-type 3D7 in the presence of aEBA-175 or EBA-140
antibodies (see Figure 4C). Although inhibitory antibodies
against EBA-181 are not available [10], it is clear that this
ligand is not involved since its unknown receptor, receptor E,
is chymotrypsin-sensitive [10]. Other possible ligands that
may compensate for loss of PfRh2b are the other three
functional PfRh proteins. PfRh1 binds to the erythrocyte via
an unknown receptor, Y, that is chymotrypsin-resistant but
neuraminidase-sensitive [7,27]. However, it is present at
relatively low levels in 3D7 and cannot deﬁne the entire
phenotype, given that 3D7DRh2b invasion is only moderately
neuraminidase-sensitive [8]. This leaves either PfRh2a, PfRh4
(the receptors of which are unknown or not fully charac-
terized [45]), or another as yet uncharacterized invasion
protein. Therefore, at present it is not possible to identify the
invasion ligand(s) that compensate for the loss of PfRh2b.
The Absence of the Rh2b-Independent Pathway in the
Wild-Type Parent Suggests a Molecular Hierarchy
Mediates Invasion
In the absence of any differences in mRNA or protein level,
the inability of the wild-type parent to invade using the same
pathway as the 3D7DRh2b parasite suggests that the presence
of PfRh2b obscures other potential receptor-mediated path-
ways. This is supported by our inability to adapt 3D7 parasites
to chymotrypsin-treated erythrocytes following long-term
selection. Since 3D7 does not become more resistant to
enzyme treatment, this shows that the shift toward using an
alternative receptor-mediated pathway is only possible
following the removal of PfRh2b but crucially not its target
Figure 5. Long-Term Selection of (A) 3D7 and (B) 3D7DRh2b in
Erythrocytes Pretreated with Chymotrypsin (1.5 mg/ml) and Trypsin
(0.1 mg/ml) Shows No Significant Change in Receptor Dependency
Parasitemia was measured by microscopy; then cultures were diluted
down to 0.5% parasitemia at 48-h intervals. Cultures were maintained for
greater than 30 d. Secondary y-axis represents invasion into enzyme-
treated erythrocytes as a percentage of invasion into untreated
erythrocytes, with a regression line plotted across the values.
DOI: 10.1371/journal.ppat.0010037.g005
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levels and inability to alter invasion in the presence of PfRh2b
suggests that a molecular hierarchy operates to direct which
receptor-mediated pathway is used by the 3D7 parasite to
invade.
When the parasite begins to invade the erythrocyte (see
Figure 1), the tight junction is likely to contain micronemal
proteins such as EBA-175, EBA-181, and EBA-140 and
rhoptry proteins such as the PfRhs [8,27,29], which together
will direct the receptor-mediated pathway used to invade. In
3D7, EBA-175 and PfRh2b are likely to dominate these
interactions, with EBA-140, EBA-181, and PfRh1 playing only
minor roles as evidenced by the lack of phenotype following
their functional disruption [8,14,27] (J. Thompson and A. F.
Cowman, unpublished data).
For invasion by wild-type 3D7 parasites, removal of the
receptors for EBA-140, EBA-175, EBA-181, and PfRh1 by
neuraminidase treatment [4,7,10,11,14,27,33], results in uti-
lization of the PfRh2b pathway. When erythrocytes are
treated with chymotrypsin, the receptors for PfRh2b [8] and
EBA-181 [10] are removed, but invasion proceeds via the
interaction of the remaining EBA proteins and any residual
PfRh1 function. It is of note that although EBA-175 and EBA-
140 both function in invasion (as demonstrated by the
antibody inhibition data; see Figure 4C), it is clear that
EBA-175 is dominant to the role of EBA-140 [14,33], a feature
that is supported by the evidence for diversifying selection
operating on EBA-175 but not (detectably) on EBA-140 [46].
It is possible that the EBA proteins may compensate for and
function simultaneously with Rh (as previously suggested)
[47], although they are structurally distinct protein families.
For 3D7DEBA-175 parasites, chymotrypsin treatment dra-
matically reduces the efﬁciency of invasion in 3D7DEBA-175
(,10% [33]) and can be explained by the absence of the
PfRh2b pathway, which is chymotrypsin-sensitive. Critically,
like the parental 3D7, no invasion ligand is present that can
rescue invasion following chymotrypsin treatment, suggesting
PfRh2b still dominates SA-independent invasion.
Finally, for 3D7DRh2b parasites, pretreatment with neu-
raminidase removes the receptors for EBA (and PfRh1), but
the chymotrypsin-resistant pathway of 3D7DRh2b can com-
pensate for their absence, it being SA-independent.
The presence of a secondary receptor-mediated pathway
for invasion being redeployed from a subordinate position
also appears to explain the uncovering of an unrelated
invasion pathway in the T994 parasite strain following
disruption of the PfRh1 ligand [27]. Here, in the absence of
any noticeable changes in other invasion ligands, the knock-
out parasite becomes more neuraminidase- and trypsin-
resistant than in wild-type T994 [27]. Following the proposed
model, PfRh1 function dominates invasion in T994, but with
its removal (by Rh1 disruption) a secondary ligand compen-
sates for its lost function in the tight junction, again via a new
receptor-mediated pathway.
While these data appear to explain 3D7 and T994 invasion,
they clearly do not ﬁt all the invasion phenotypes [9]
associated with these ligand families. In particular, recent
work with W2mef, either following selection on neuramini-
dase-treated cells or after knockout of EBA-175, has shown
activation of another ligand PfRh4; this activation is critical
for switching to the new SA-independent invasion phenotype
[45].
Functional Consequences of Utilization of the PfRh and
EBA Families
Variation and expression of PfRh and EBA proteins in both
laboratory and ﬁeld strains is likely to underlie invasion
phenotypes [8,20–22,27]. Evidence from the mouse malaria
parasite, Plasmodium yoelii, for the differential transcription of
members of the Py235 gene family (a family closely related to
the PfRh family) across life cycle stages [48], suggests that
variable transcription may be a general feature of Rh-related
proteins in Plasmodia. The placement of Rh and EBA genes in
subtelomeric regions of the genome may allow them to be
selectively switched on or off [49], as has been recently
demonstrated for Rh4 in W2mef [45]. It is therefore possible
that the invasion pathways used (as determined by expression
of invasion ligand) by individual clones of P. falciparum may be
selected to change through time. This might be evidenced by
changes in the invasion phenotype of infecting parasites
across the lifetime of an exposed human host, akin to the
situation described for virulence genes [50], arbitrated by
immune-mediated selection where the most commonly used
invasion ligand is constantly selected against. Thus at the
population level, successful strategies for preventing malaria
disease that are directed against invasion will need to include
both dominant and secondary ligands to reduce the like-
lihood of selection for alternative pathways.
Materials and Methods
Parasite cultures and transfection. P. falciparum asexual parasites
were maintained in human erythrocytes (blood group Oþ)a ta
hematocrit of 4% with 10% Albumax II (GIBCO, San Diego,
California, United States) [51]. The 3D7 was originally obtained from
David Walliker at Edinburgh University. Parasites 3D7DRh2b,
3D7DEBA-175, and 3D7DEBA-140 were generated in previous studies
[8,14,33]. D10 is cloned from Papua New Guinea isolate FC27.
Cultures were synchronized as described [52].
For disruption of the PfRh3 gene in 3D7 and 3D7DRh2b, parasites
were transfected with 80–100 lg of plasmid (QIAGEN) as described
[41]. Positive selection for transfectants was achieved using 2.5 lg/ml
of blasticidin-S [53] with negative selection against the plasmid
backbone using 5 ﬂuoro-cytosine (A. G. Maier and A. F. Cowman,
unpublished data).
The PCC4-Rh3 vector for disruption of the PfRh3 gene was
constructed using pCC4, a derivative of the pHTK plasmid [41],
modiﬁed to include the BSD gene [53]) under control of histidine-
rich protein (hrp) 2 promoter and the cytosine deaminase gene (A. G.
Maier and A. F. Cowman, unpublished data). The 59 and 39 ﬂanks
(both approximately 1 kb) for homologous recombination into the
PfRh3 gene were ampliﬁed from 3D7 genomic DNA with the primer
pairs 59-GATCccgcggGGAAGGAGTAAAGTTTCGAAGG-39/59-
GATCtctagaCTTATCTCCCAATATTCTC-39 (inserts a 59 SacII site
and 39 XbaI site) and 59-GATCgaattcGACGGATTAGTTGAAAA
TAAATCC-39/59-GATCccatggCCATCAACTAAGGTTTCATC-39 (in-
serts a 59 EcoRI site and 39 NcoI site), respectively. The 59 and 39
ﬂanks were inserted into the vector to ﬂank the BSD cassette. Plasmid
integration was conﬁrmed by Southern blot, using a 59 Rh3 ﬂank as a
probe, following standard protocols.
Long-term growth assays were undertaken for cultures of 3D7 and
3D7DRh2b maintained in erythrocytes treated with 1.5 mg/ml
chymotrypsin (Worthington Biochemical, Lakewood, New Jersey,
United States) and 0.1 mg/ml trypsin (Sigma, St. Louis, Missouri,
United States). Percentage parasitemia was calculated per 1,000 red
cells by microscopy every 48 h at early to midtrophozoite stage.
Parasitemia was adjusted to 0.5% for the next round of invasion.
RT-PCR and microarray analysis. Total RNA was isolated from
synchronized parasites 40–48 h postinvasion, using TRIzol (Invitro-
gen, Carlsbad, California, United States). RNA was further puriﬁed
using DNaseI digestion by passage over an RNAeasy column (Qiagen,
Valencia, California, United States).
Total RNA (5 lg) was reverse transcribed either with or without
SuperScript II reverse transcriptase, using random hexamers (Invi-
trogen). A LightCycler (Roche, Basel, Switzerland) was used to
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with PfRh or EBA gene-speciﬁc primers. Serial dilutions of 3D7
genomic DNA were used as standard controls. Relative expression
ratios of EBA and PfRh genes compared to three reference genes, actin
and histone2b (constitutively expressed [34]) and msp2 (transcribed late
in the erythrocytic cycle [34]) were calculated for each strain. Each
gene expression level was calculated as the average of three
independent ampliﬁcations for 3D7 and 3D7DRh2b, although only
two rounds were undertaken for D10. Samples with no reverse
transcriptase were used to control for possible genomic DNA
contamination of cDNA preparations.
RT-PCR for veriﬁcation of the PfRh3 gene deletion was as
described above, except reactions were separated on 1% TBE agarose
gels to determine presence or absence of cDNA product; RT-negative
reactions were included to ensure ampliﬁcation was from cDNA and
not genomic DNA. Primers used were Rh2aRTfwd 59-GATGAGGT
CATAAAAGATAATGAG-39, Rh2aRTrev 59-GAACATCATCATTCG
GTTCAAAAGC-39, Rh3RTfwd 59-CAACGAATCAAGCACGTTTACC-
39, and Rh3RTfwd 59-CTTATCATTTCTAAGGTAGAACC-39.
cRNA was produced from cDNA using a T7-in vitro transcription
kit (MEGAscript Kit, Ambion, Austin, Texas, United States) and used
to hybridize to an Affymetrix (Santa Clara, California, United States)
oligonucleotide DNA microarray as previously described [34]. Signal
intensity and background noise correction were measured using the
MOID [35], RMA [36], or GCRMA [37] algorithms. Differential
expression was assessed for each parasite strain compared to 3D7
wild type by calculating a moderated t-statistic for each gene using the
Limma package [54]. Features of genes that changed their transcrip-
tional activity were investigated through publicly available databases
held at http://www.PlasmoDB.org and http://www.geneDB.org.
SDS/PAGE and immunoblot analysis. Parasite culture supernatants
were obtained from cultures following schizont rupture. Proteins
were separated by SDS-polyacrylamide gels and transferred to
membranes (Schleicher and Schuell Bioscience, Dassel, Germany)
and probed with afﬁnity-puriﬁed rabbit polyclonal antibodies raised
against PfRh1 [8], PfRh2a and PfRh2b [7], EBA-140 [11], EBA-175 [23],
and EBA-181 [10]. Supernatant loading was controlled using anti-
bodies raised against SERA5 (a generous gift from S. Miller and B.
Crabb). Blots were processed by enhanced chemiluminescence (ECL;
Amersham Biosciences, Little Chalfont, United Kingdom).
Invasion inhibition assays. Erythrocyte invasion was assayed using
normal and chymotrypsin-treated cells in the presence or absence of
protein G puriﬁed rabbit anti-EBA-140 (raised against the F2
domain) [14] and rabbit anti-EBA-175 (raised against the region
between the F2 and the 39 cysteine-rich domain) [23]. Ring-stage
cultures were split, half of which was treated with 1.5mg/ml
chymotrypsin (Worthington Biochemical), washed, and resuspended
in complete medium. Invasion assays were prepared in triplicate,
using 100-ll aliquots of culture at a ﬁnal hematocrit of 4% and
parasitemia of 0.5% in 96-well ﬂat-bottom microtiter plates (Becton
Dickinson, Franklin Lakes, New Jersey, United States). Rabbit anti-
EBA-140, anti-EBA-175, or NRS was added at a ﬁnal concentration of
1 mg/ml in PBS. A PBS nonserum control was included. Control wells
were smeared 72 h postassay preparation to determine life cycle stage
(mid- to late-trophozoites postreinvasion); 10 ll of each resuspended
assay well was added to 190 ll of ﬁltered 10 lg/ml ethidium bromide
in PBS. This was mixed and incubated for 5 min at room temper-
ature. Parasitemia was measured using a FACScan (Becton Dick-
inson). Assays were performed on at least three separate occasions to
calculate the mean and standard error of invasion inhibition relative
to the NRS control.
Supporting Information
Dataset S1. Comparative Gene Expression
Comparative gene expression levels for 3D7, 3D7DRh2b, 3D7DEBA-
175, 3D7DEBA-140, and D10 late-stage parasites using Affymetrix
gene chips. Signal intensity and background noise correction were
measured using the MOID [35], RMA [36], or GCRMA [37] algorithms.
Found at DOI: 10.1371/journal.ppat.0010037.sd001 (5.1 MB XLS).
Dataset S2. Invasion Genes: MOID
As in Dataset S1, but analysis is restricted to those genes that are
expressed at similar times to genes whose products are known to be
involved in invasion (clusters 4, 13, 14, and 15 [34]), excluding the
known virulence genes (vars, riﬁns, and stevors [39]). Signal intensity
and background noise correction were measured using the MOID [35]
algorithm.
Found at DOI: 10.1371/journal.ppat.0010037.sd002 (134 KB XLS).
Dataset S3. Invasion Genes: RMA
As in Dataset S2, but signal intensity and background noise
correction were measured using the RMA [36] algorithm.
Found at DOI: 10.1371/journal.ppat.0010037.sd003 (134 KB XLS).
Dataset S4. Invasion Genes: GCRMA
As in Dataset S2, but signal intensity and background noise
correction were measured using the GCRMA [37] algorithm.
Found at DOI: 10.1371/journal.ppat.0010037.sd004 (134 KB XLS).
Dataset S5. Summary of PfRh3 Activation in 3D7DEBA-140 and
3D7DEBA-175 Parasite Lines
Found at DOI: 10.1371/journal.ppat.0010037.sd005 (32 KB DOC).
Accession Numbers
The PlasmoDB (http://plasmodb.org/PlasmoDB.shtml) accession num-
bers for the genes discussed in this paper are EBA-140 (MAL13P1.60),
EBA-165 (PFD1155w), EBA-175 (PF07_0128), EBA-181 (PFA0125c),
PfRh1 (PFD0110w), PfRh2a (PF13_0198), PfRh2b (MAL13P1.176),
PfRh3 (PFL2520w), PfRh4 (PFD1150c), and other genes (PFE1465w,
PFB0680w, PFF0670w, PF08_0036, PF13_0173, and PF14_0567).
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